Skip to main content
SB24-203

Prescription Drug Board Consider Rare Disease Advisory Council

Type Bill
Session 2024 Regular Session
Subjects
Insurance

Concerning requiring the Colorado prescription drug affordability review board to consider input from the Colorado rare disease advisory council under certain circumstances.

Bill Summary:

Current law requires the Colorado prescription drug affordability review board (board) to take certain measures in determining whether to conduct an affordability review for an identified prescription drug. The act requires the board, in making such a determination, to consider whether the drug has an approved orphan drug designation for one or more rare diseases and no other indications and, if so, to consider input from consumers and the Colorado rare disease advisory council (council).

Current law requires the board, in performing an affordability review, to consider certain information. The act requires the board to consider input from the council.

APPROVED by Governor June 6, 2024

EFFECTIVE August 7, 2024
(Note: This summary applies to this bill as enacted.)

Status

Became Law

Introduced

Passed

Became Law

Related Documents & Information

Date Version Documents
06/06/2024 Signed Act PDF
05/16/2024 Final Act PDF
05/05/2024 Rerevised PDF
05/04/2024 Revised PDF
04/23/2024 Reengrossed PDF
04/22/2024 Engrossed PDF
04/08/2024 Introduced PDF
Date Version Documents
06/21/2024 FN2 PDF
04/15/2024 FN1 PDF
Activity Vote Documents
Refer Senate Bill 24-203 to the Committee of the Whole. The motion passed on a vote of 12-0. Vote summary
Activity Vote Documents
Refer Senate Bill 24-203 to the Committee of the Whole and with a recommendation that it be placed on the consent calendar. The motion passed on a vote of 5-0. Vote summary
Date Calendar Motion Vote Vote Document
05/05/2024 Third Reading BILL
55
AYE
7
NO
3
OTHER
Vote record
Date Calendar Motion Vote Vote Document
04/23/2024 Third Reading BILL
33
AYE
0
NO
2
OTHER
Vote record
Date Location Action
06/06/2024 Governor Governor Signed
05/16/2024 Governor Sent to the Governor
05/16/2024 House Signed by the Speaker of the House
05/16/2024 Senate Signed by the President of the Senate
05/05/2024 House House Third Reading Passed - No Amendments
05/04/2024 House House Second Reading Special Order - Passed - No Amendments
05/02/2024 House House Second Reading Laid Over Daily - No Amendments
04/29/2024 House House Committee on Health & Human Services Refer Unamended to House Committee of the Whole
04/23/2024 House Introduced In House - Assigned to Health & Human Services
04/23/2024 Senate Senate Third Reading Passed - No Amendments
04/22/2024 Senate Senate Second Reading Special Order - Passed - No Amendments
04/18/2024 Senate Senate Committee on State, Veterans, & Military Affairs Refer Unamended - Consent Calendar to Senate Committee of the Whole
04/08/2024 Senate Introduced In Senate - Assigned to State, Veterans, & Military Affairs
Effective Date Chapter # Title Documents
08/07/2024 454 Rx Drug Board Consider Rare Disease Adv Council PDF